Morgan Leigh Brown

Publications

1. Proposed Quality Metrics for Congenital Cardiac Anesthesia: A Scoping Review. Anesth Analg. 2025 Feb 01; 140(2):397-408. View Abstract
2. Intraoperative cardiac arrest in patients undergoing congenital cardiac surgery. JTCVS Open. 2024 Dec; 22:427-437. View Abstract
3. Correlation of Transthoracic Echocardiographic Estimates of Right Ventricular Pressure with Right Ventricular Pressure Measurements on Cardiac Catheterization in Children with Pulmonary Hypertension. J Cardiothorac Vasc Anesth. 2024 Dec; 38(12):3101-3108. View Abstract
4. Erector spinae plane blocks for opioid-sparing multimodal pain management after pediatric cardiac surgery. J Thorac Cardiovasc Surg. 2024 Dec; 168(6):1742-1750.e9. View Abstract
5. The Minimum Requirements for a Pediatric Cardiac Surgical Site: What is Needed? J Cardiothorac Vasc Anesth. 2024 Jun; 38(6):1302-1304. View Abstract
6. Predictors and outcomes of perioperative cardiac arrest in children undergoing noncardiac surgery. BJA Open. 2023 Dec; 8:100244. View Abstract
7. Predictors of anesthesia ready time: Analysis and benchmark data. JTCVS Open. 2023 Sep; 15:446-453. View Abstract
8. The Society of Thoracic Surgeons-Congenital Heart Surgery Database 2017 to 2021: What Is Known and Where Clinicians Can Still Improve. J Cardiothorac Vasc Anesth. 2023 10; 37(10):1859-1861. View Abstract
9. A Review of Biventricular Repair for the Congenital Cardiac Anesthesiologist. Semin Cardiothorac Vasc Anesth. 2023 Mar; 27(1):51-63. View Abstract
10. Anaesthesia for non-cardiac surgery in children and young adults with Fontan physiology. Cardiol Young. 2023 Oct; 33(10):1896-1901. View Abstract
11. Race and Outcomes in Patients with Congenital Cardiac Disease in an Enhanced Recovery Program. J Cardiothorac Vasc Anesth. 2022 09; 36(9):3603-3609. View Abstract
12. Post-operative vomiting and enhanced recovery after congenital cardiac surgery. Cardiol Young. 2023 Feb; 33(2):260-265. View Abstract
13. The Practice of Pediatric Cardiac Anesthesiology in the United States. Anesth Analg. 2022 03 01; 134(3):532-539. View Abstract
14. Anesthesia in Children With Pulmonary Hypertension: Clinically Significant Serious Adverse Events Associated With Cardiac Catheterization and Noncardiac Procedures. J Cardiothorac Vasc Anesth. 2022 06; 36(6):1606-1616. View Abstract
15. Enhancing Recovery in Congenital Cardiac Surgery. Ann Thorac Surg. 2022 11; 114(5):1754-1761. View Abstract
16. Dosing of Opioid Medications During and After Pediatric Cardiac Surgery for Children With Down Syndrome. J Cardiothorac Vasc Anesth. 2022 01; 36(1):195-199. View Abstract
17. Relationship of Preoperative Thyroid Dysfunction to Clinical Outcomes in Pediatric Cardiac Surgery. J Clin Endocrinol Metab. 2021 04 23; 106(5):e2129-e2136. View Abstract
18. The Use of Regional Catheters in Children Undergoing Repair of Aortic Coarctation. J Cardiothorac Vasc Anesth. 2021 12; 35(12):3694-3699. View Abstract
19. Bilateral Erector Spinae Blocks Decrease Perioperative Opioid Use After Pediatric Cardiac Surgery. J Cardiothorac Vasc Anesth. 2021 Jul; 35(7):2082-2087. View Abstract
20. Superior Cavopulmonary Connection: Its Physiology, Limitations, and Anesthetic Implications. Semin Cardiothorac Vasc Anesth. 2020 Dec; 24(4):337-348. View Abstract
21. Incidence and predictors of postoperative nausea and vomiting in children undergoing electrophysiology ablation procedures. Paediatr Anaesth. 2020 02; 30(2):147-152. View Abstract
22. Initial experience introducing an enhanced recovery program in congenital cardiac surgery. J Thorac Cardiovasc Surg. 2020 11; 160(5):1313-1321.e5. View Abstract
23. Anesthesia in Pediatric Patients With Congenital Heart Disease Undergoing Noncardiac Surgery: Defining the Risk. J Cardiothorac Vasc Anesth. 2020 Feb; 34(2):470-478. View Abstract
24. Commentary: Between the devil and the deep blue sea: A new palliation for high-risk neonates with hypoplastic left heart syndrome. J Thorac Cardiovasc Surg. 2019 08; 158(2):e65-e66. View Abstract
25. Never Say Never: The Use of Nitric Oxide in Patients With Obstructed Pulmonary Veins: A Case Report. A A Pract. 2019 Mar 15; 12(6):205-207. View Abstract
26. Complications of Transthoracic Intracardiac and Central Venous Lines in Neonates Undergoing Cardiac Surgery. Pediatr Cardiol. 2019 Apr; 40(4):733-737. View Abstract
27. Williams Syndrome and Anesthesia for Non-cardiac Surgery: High Risk Can Be Mitigated with Appropriate Planning. Pediatr Cardiol. 2018 Aug; 39(6):1123-1128. View Abstract
28. Recombinant Factor VIIa Is Associated With Increased Thrombotic Complications in Pediatric Cardiac Surgery Patients. Anesth Analg. 2017 05; 124(5):1431-1436. View Abstract
29. Twenty Years of Anesthetic and Perioperative Management of Patients With Tetralogy of Fallot With Absent Pulmonary Valve. J Cardiothorac Vasc Anesth. 2017 Jun; 31(3):918-921. View Abstract
30. Can't you just pull the data? The limitations of using of the electronic medical record for research. Paediatr Anaesth. 2016 Nov; 26(11):1034-1035. View Abstract
31. Post-Operative Outcomes in Children With and Without Congenital Heart Disease Undergoing Noncardiac Surgery. J Am Coll Cardiol. 2016 Feb 23; 67(7):793-801. View Abstract
32. Patients with single ventricle physiology undergoing noncardiac surgery are at high risk for adverse events. Paediatr Anaesth. 2015 Aug; 25(8):846-851. View Abstract
33. Coarctation of the aorta: lifelong surveillance is mandatory following surgical repair. J Am Coll Cardiol. 2013 Sep 10; 62(11):1020-5. View Abstract
34. Early thrombosis risk in patients with biologic valves in the aortic position. J Thorac Cardiovasc Surg. 2012 Jul; 144(1):108-11. View Abstract
35. Can the impact of change of surgical teams in cardiovascular surgery be measured by operative mortality or morbidity? A propensity adjusted cohort comparison. Ann Surg. 2011 Feb; 253(2):385-92. View Abstract
36. Clinical outcome of asymptomatic severe aortic stenosis with medical and surgical management: importance of STS score at diagnosis. Ann Thorac Surg. 2010 Dec; 90(6):1876-83. View Abstract
37. Regression in left ventricular mass after aortic valve replacement for chronic aortic regurgitation is unrelated to prosthetic valve size. J Thorac Cardiovasc Surg. 2011 Aug; 142(2):e5-9. View Abstract
38. Data entry and data accuracy. J Thorac Cardiovasc Surg. 2010 Nov; 140(5):960-1. View Abstract
39. Relationship between left ventricular mass, wall thickness, and survival after subaortic septal myectomy for hypertrophic obstructive cardiomyopathy. J Thorac Cardiovasc Surg. 2011 Feb; 141(2):439-43. View Abstract
40. Late outcomes of reintervention on the descending aorta after repair of aortic coarctation. Circulation. 2010 Sep 14; 122(11 Suppl):S81-4. View Abstract
41. Axillary arteriovenous fistula for the palliation of complex cyanotic congenital heart disease: is it an effective tool? J Thorac Cardiovasc Surg. 2011 Jan; 141(1):188-92. View Abstract
42. Variability in data: the Society of Thoracic Surgeons National Adult Cardiac Surgery Database. J Thorac Cardiovasc Surg. 2010 Aug; 140(2):267-73. View Abstract
43. Apical myectomy: a new surgical technique for management of severely symptomatic patients with apical hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2010 Mar; 139(3):634-40. View Abstract
44. A pilot study of electronic cardiovascular operative notes: qualitative assessment and challenges in implementation. J Am Coll Surg. 2010 Feb; 210(2):178-84. View Abstract
45. Ebstein malformation of the tricuspid valve: current concepts in management and outcomes. Curr Treat Options Cardiovasc Med. 2009 Oct; 11(5):396-402. View Abstract
46. The adult with congenital heart disease: medical and surgical considerations for management. Curr Opin Pediatr. 2009 Oct; 21(5):561-4. View Abstract
47. Operative strategies for pulmonary artery occlusion secondary to mediastinal fibrosis. Ann Thorac Surg. 2009 Jul; 88(1):233-7. View Abstract
48. Results of mitral valve annuloplasty with a standard-sized posterior band: is measuring important? J Thorac Cardiovasc Surg. 2009 Oct; 138(4):886-91. View Abstract
49. Indexed left ventricular dimensions best predict survival after aortic valve replacement in patients with aortic valve regurgitation. Ann Thorac Surg. 2009 Apr; 87(4):1170-5; discussion 1175-6. View Abstract
50. Comparison of the outcome of porcine bioprosthetic versus mechanical prosthetic replacement of the tricuspid valve in the Ebstein anomaly. Am J Cardiol. 2009 Feb 15; 103(4):555-61. View Abstract
51. What are patients really telling us? Comparison of survey responses and the medical record in cardiovascular surgical patients. Ann Thorac Surg. 2008 Dec; 86(6):1888-96. View Abstract
52. Ministernotomy versus conventional sternotomy for aortic valve replacement: a systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2009 Mar; 137(3):670-679.e5. View Abstract
53. Effect of operation for Ebstein anomaly on left ventricular function. Am J Cardiol. 2008 Dec 15; 102(12):1724-7. View Abstract
54. Comparison of coronary revascularization procedures in octogenarians: a systematic review and meta-analysis. Nat Clin Pract Cardiovasc Med. 2008 Nov; 5(11):738-46. View Abstract
55. Conduit choice for coronary artery bypass grafting after mediastinal radiation. J Thorac Cardiovasc Surg. 2008 Nov; 136(5):1167-71. View Abstract
56. Mediastinal paragangliomas: the mayo clinic experience. Ann Thorac Surg. 2008 Sep; 86(3):946-51. View Abstract
57. Functional status after operation for Ebstein anomaly: the Mayo Clinic experience. J Am Coll Cardiol. 2008 Aug 05; 52(6):460-6. View Abstract
58. From randomized trials to registry studies: translating data into clinical information. Nat Clin Pract Cardiovasc Med. 2008 Oct; 5(10):613-20. View Abstract
59. Is the European System for Cardiac Operative Risk Evaluation model valid for estimating the operative risk of patients considered for percutaneous aortic valve replacement? J Thorac Cardiovasc Surg. 2008 Sep; 136(3):566-71. View Abstract
60. Hypoxemia after an axial flow pump Jarvik-2000 implantation: catheter induced. J Thorac Cardiovasc Surg. 2008 Oct; 136(4):1082-3. View Abstract
61. Surgical management of obstructive hypertrophic cardiomyopathy: the gold standard. Expert Rev Cardiovasc Ther. 2008 Jun; 6(5):715-22. View Abstract
62. The outcomes of operations for 539 patients with Ebstein anomaly. J Thorac Cardiovasc Surg. 2008 May; 135(5):1120-36, 1136.e1-7. View Abstract
63. Aortic valve replacement in patients aged 50 to 70 years: improved outcome with mechanical versus biologic prostheses. J Thorac Cardiovasc Surg. 2008 Apr; 135(4):878-84; discussion 884. View Abstract
64. Surgical management of hypertrophic cardiomyopathy in 2007: what is new? World J Surg. 2008 Mar; 32(3):350-4. View Abstract
65. The benefits of early valve replacement in asymptomatic patients with severe aortic stenosis. J Thorac Cardiovasc Surg. 2008 Feb; 135(2):308-15. View Abstract
66. Timing of operation in asymptomatic severe aortic stenosis. Expert Rev Cardiovasc Ther. 2007 Nov; 5(6):1065-71. View Abstract
67. Safety of same-day coronary angiography in patients undergoing elective valvular heart surgery. Mayo Clin Proc. 2007 May; 82(5):572-4. View Abstract
68. Intraoperative diagnosis of isolated cardiac sarcoid. Heart Lung Circ. 2007 Aug; 16(4):315-7. View Abstract
69. Systolic anterior motion after mitral valve repair: is surgical intervention necessary? J Thorac Cardiovasc Surg. 2007 Jan; 133(1):136-43. View Abstract
70. Structural and functional conservation of error-free DNA postreplication repair in Schizosaccharomyces pombe. DNA Repair (Amst). 2002 Nov 03; 1(11):869-80. View Abstract
Show All Publications Show Fewer Publications